SCYNEXIS, Inc. (SCYX) earnings
SCYX earnings moved a median of -2.76% by the close. Quarterly and annual SCYX reports and results, each read against the price at its own news timestamp. Back to the SCYX overview →
19 measured SCYX earnings events.
Where these SCYX earnings landedvs 19 measured SCYX earnings reactions
| Middle 50% of SCYX earnings reactions | -6.88% to +0.47% |
|---|---|
| Median reaction (to close) | -2.76% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 SCYX earnings events with a measured close landed between -6.88% and +0.47%; 26% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q SCYNEXIS INC For: Mar 31 | SEC filing · Form 10-Q | +1.02% | +2.13% | |
| SCYNEXIS Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | +1.02% | +2.13% | |
| Form 10-K SCYNEXIS INC For: Dec 31 | SEC filing · Form 10-K | +5.41% | +7.09% | |
| Form 10-Q SCYNEXIS INC For: Sep 30 | SEC filing · Form 10-Q | +0.77% | -2.76% | |
| SCYNEXIS Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | +0.77% | -2.76% | |
| Form 10-Q SCYNEXIS INC For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -7.44% | |
| SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | +0.00% | -7.44% | |
| Form 10-Q SCYNEXIS INC For: Mar 31 | SEC filing · Form 10-Q | -4.75% | -11.38% | |
| SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update | Press release | -4.75% | -11.38% | |
| Form 10-K SCYNEXIS INC For: Dec 31 | SEC filing · Form 10-K | +0.00% | -5.42% | |
| Form 10-Q SCYNEXIS INC For: Sep 30 | SEC filing · Form 10-Q | +0.38% | +1.53% | |
| SCYNEXIS Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | +0.38% | +1.53% | |
| Form 10-Q SCYNEXIS INC For: Jun 30 | SEC filing · Form 10-Q | +0.15% | -6.88% | |
| SCYNEXIS Reports Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | +0.15% | -6.88% | |
| Form 10-Q SCYNEXIS INC For: Mar 31 | SEC filing · Form 10-Q | -3.29% | -5.05% | |
| SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update | Press release | -3.29% | -5.05% | |
| Form 10-K SCYNEXIS INC For: Dec 31 | SEC filing · Form 10-K | -3.25% | -1.97% | |
| Form 10-Q SCYNEXIS INC For: Sep 30 | SEC filing · Form 10-Q | +3.49% | -0.58% | |
| SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update | Press release | +3.49% | -0.58% |
Keep exploring
More SCYX: analyst actions → · SEC filings → · SCYX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CRH MEDICAL CORP (CRHM) | 431 | 0.00% | 39% |
| Globus Medical, Inc. Class A (GMED) | 431 | +0.02% | 51% |
| LeMaitre Vascular, Inc. (LMAT) | 430 | +0.05% | 54% |
| TRULIEVE CANNABIS CORP (TCNNF) | 429 | +0.41% | 58% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.